Metropolis Healthcare Share Price
Sector: Healthcare Facilities
1846.80 +4.30 (0.23%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1834.45
Today’s High
1849.6
52 Week Low
1209.25
52 Week High
1935
1840.25 +2.05 (0.11%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1832.6
Today’s High
1860
52 Week Low
1209.25
52 Week High
1933.5
Key Metrics
- Market Cap (In Cr) 9569.03
- Beta 0.68
- Div. Yield (%) 0.21
- P/B 9.68
- TTM P/E 68.92
- Peg Ratio 1.68
- Sector P/E 28.96
- D/E -
- Open Price 1847.45
- Prev Close 1842.5
Metropolis Healthcare Analysis
Price Analysis
-
1 Week8.92%
-
3 Months9.38%
-
6 Month16.25%
-
YTD11.31%
-
1 Year44.06%
Risk Meter
- 34% Low risk
- 34% Moderate risk
- 34% Balanced Risk
- 34% High risk
- 34% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 2
- 2
- 2
- Buy
- 5
- 5
- 5
- 4
- Hold
- 1
- 1
- 0
- 0
- Sell
- 4
- 4
- 4
- 4
- Strong Sell
- 2
- 2
- 2
- 2
- Total
- 15
- 14
- 13
- 12
Metropolis Healthcare News
Vodafone Idea, Bandhan Bank among 10 stocks under F&O ban list on April 18
1 min read . 18 Apr 2024Bandhan Bank, Exide Industries, GNFC among 11 stocks under F&O ban list today
1 min read . 16 Apr 2024Idea, PEL, Metropolis Healthcare among 9 stocks under F&O ban list today
1 min read . 15 Apr 2024Metropolis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2023
- Total Revenue
- 1148.21
- Selling/ General/ Admin Expenses Total
- 575.25
- Depreciation/ Amortization
- 89.22
- Other Operating Expenses Total
- 5.77
- Total Operating Expense
- 944.64
- Operating Income
- 203.57
- Net Income Before Taxes
- 187.5
- Net Income
- 142.88
- Diluted Normalized EPS
- 27.83
- Period
- 2023
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022
- Total Revenue
- 1228.34
- Selling/ General/ Admin Expenses Total
- 585.21
- Depreciation/ Amortization
- 63.22
- Other Operating Expenses Total
- 1.73
- Total Operating Expense
- 930.99
- Operating Income
- 297.35
- Net Income Before Taxes
- 293.35
- Net Income
- 214.18
- Diluted Normalized EPS
- 39.43
- Period
- 2022
- Total Assets
- 1530.29
- Total Liabilities
- 644.1
- Total Equity
- 886.2
- Tangible Book Valueper Share Common Eq
- 13.72
- Period
- 2022
- Cashfrom Operating Activities
- 253.27
- Cashfrom Investing Activities
- -737.57
- Cashfrom Financing Activities
- 162.52
- Net Changein Cash
- -323.14
- Period
- 2021
- Total Revenue
- 997.99
- Selling/ General/ Admin Expenses Total
- 436.9
- Depreciation/ Amortization
- 45.94
- Other Operating Expenses Total
- 2.62
- Total Operating Expense
- 755.08
- Operating Income
- 242.91
- Net Income Before Taxes
- 244.32
- Net Income
- 183.1
- Diluted Normalized EPS
- 35.79
- Period
- 2021
- Total Assets
- 1004.42
- Total Liabilities
- 297.81
- Total Equity
- 706.6
- Tangible Book Valueper Share Common Eq
- 113.83
- Period
- 2021
- Cashfrom Operating Activities
- 249.03
- Cashfrom Investing Activities
- 61.7
- Cashfrom Financing Activities
- -32.69
- Net Changein Cash
- 279.42
- Period
- 2020
- Total Revenue
- 856.41
- Selling/ General/ Admin Expenses Total
- 415.95
- Depreciation/ Amortization
- 39.27
- Other Operating Expenses Total
- 4.68
- Total Operating Expense
- 686.77
- Operating Income
- 169.63
- Net Income Before Taxes
- 168.73
- Net Income
- 127.33
- Diluted Normalized EPS
- 25.84
- Period
- 2020
- Total Assets
- 752.23
- Total Liabilities
- 228.74
- Total Equity
- 523.5
- Tangible Book Valueper Share Common Eq
- 79.99
- Period
- 2020
- Cashfrom Operating Activities
- 215
- Cashfrom Investing Activities
- -104.83
- Cashfrom Financing Activities
- -55.32
- Net Changein Cash
- 55.8
- Period
- 2019
- Total Revenue
- 761.18
- Selling/ General/ Admin Expenses Total
- 365.89
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 580.84
- Operating Income
- 180.34
- Net Income Before Taxes
- 186.55
- Net Income
- 120.15
- Diluted Normalized EPS
- 24.01
- Period
- 2019
- Total Assets
- 552.64
- Total Liabilities
- 134.1
- Total Equity
- 418.54
- Tangible Book Valueper Share Common Eq
- 63.1
- Period
- 2019
- Cashfrom Operating Activities
- 90.15
- Cashfrom Investing Activities
- 35.34
- Cashfrom Financing Activities
- -118.15
- Net Changein Cash
- 7.9
- Period
- 2018
- Total Revenue
- 647.16
- Selling/ General/ Admin Expenses Total
- 300.46
- Depreciation/ Amortization
- 19.02
- Other Operating Expenses Total
- 3.78
- Total Operating Expense
- 487.57
- Operating Income
- 159.59
- Net Income Before Taxes
- 163.68
- Net Income
- 104.24
- Diluted Normalized EPS
- 21.22
- Period
- 2018
- Total Assets
- 530.34
- Total Liabilities
- 115.57
- Total Equity
- 414.77
- Tangible Book Valueper Share Common Eq
- 63.7
- Period
- 2018
- Cashfrom Operating Activities
- 103.15
- Cashfrom Investing Activities
- 1.88
- Cashfrom Financing Activities
- -87.3
- Net Changein Cash
- 17.96
- Period
- 2023-12-31
- Total Revenue
- 291.12
- Selling/ General/ Admin Expenses Total
- 69.51
- Depreciation/ Amortization
- 24.99
- Other Operating Expenses Total
- 97.42
- Total Operating Expense
- 251.26
- Operating Income
- 39.86
- Net Income Before Taxes
- 36.85
- Net Income
- 27.16
- Diluted Normalized EPS
- 5.28
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 308.5
- Selling/ General/ Admin Expenses Total
- 69.75
- Depreciation/ Amortization
- 22.24
- Other Operating Expenses Total
- 99.86
- Total Operating Expense
- 255.93
- Operating Income
- 52.57
- Net Income Before Taxes
- 48.11
- Net Income
- 35.45
- Diluted Normalized EPS
- 6.9
- Period
- 2023-09-30
- Total Assets
- 1509.14
- Total Liabilities
- 462.64
- Total Equity
- 1046.5
- Tangible Book Valueper Share Common Eq
- 41.95
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 108.59
- Cashfrom Investing Activities
- -48.06
- Cashfrom Financing Activities
- -73.55
- Net Changein Cash
- -17.9
- Period
- 2023-06-30
- Total Revenue
- 277.09
- Selling/ General/ Admin Expenses Total
- 65.06
- Depreciation/ Amortization
- 20.82
- Other Operating Expenses Total
- 89.71
- Total Operating Expense
- 234.97
- Operating Income
- 42.12
- Net Income Before Taxes
- 39.19
- Net Income
- 28.8
- Diluted Normalized EPS
- 5.62
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 282.55
- Selling/ General/ Admin Expenses Total
- 64.31
- Depreciation/ Amortization
- 23.43
- Other Operating Expenses Total
- 88.1
- Total Operating Expense
- 235.69
- Operating Income
- 46.85
- Net Income Before Taxes
- 41.9
- Net Income
- 33.36
- Diluted Normalized EPS
- 6.5
- Period
- 2023-03-31
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022-12-31
- Total Revenue
- 285.46
- Selling/ General/ Admin Expenses Total
- 64.57
- Depreciation/ Amortization
- 23.03
- Other Operating Expenses Total
- 84.61
- Total Operating Expense
- 238
- Operating Income
- 47.46
- Net Income Before Taxes
- 47.97
- Net Income
- 35.8
- Diluted Normalized EPS
- 6.97
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Metropolis Healthcare Technical
Moving Average
SMA
- 5 Day1825.58
- 10 Day1799.05
- 20 Day1794.07
- 50 Day1716.22
- 100 Day1686.51
- 300 Day1583.02
Metropolis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Krishna Instit Of Medical Sciences
- 1955.75
- 63.8
- 3.37
- 2357
- 1490.55
- 15651.44
- Rainbow Childrens Medicare
- 1389
- 48.75
- 3.64
- 1649
- 856
- 14098.63
- Metropolis Healthcare
- 1846.8
- 4.3
- 0.23
- 1935
- 1209.25
- 9457.58
- Vijaya Diagnostic Centre
- 800
- 24.75
- 3.19
- 838
- 367.05
- 8187.66
- Healthcare Global Enterprises
- 359.15
- -5.15
- -1.41
- 401
- 276.45
- 4996.35
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Krishna Instit Of Medical Sciences
- 48.16
- 9.37
- 22.72
- 13.59
- Rainbow Childrens Medicare
- 63.17
- 12.77
- -
- -
- Metropolis Healthcare
- 66.48
- 9.59
- 24.34
- 15.88
- Vijaya Diagnostic Centre
- 68.34
- 12.5
- 22.14
- 21.2
- Healthcare Global Enterprises
- 168.95
- 5.86
- -7.77
- -5.21
Metropolis Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 0.59%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 21-May-24
- Audited Results
- 02-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results & Interim Dividend
- 02-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results
- 10-Feb-23
- Quarterly Results & Interim Dividend
- 08-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- 18-Jul-22
- Others
- 24-May-22
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 30-Oct-23
- 28-Sept-23
- POM
- 17-Aug-23
- 24-Jul-23
- AGM
- 11-Aug-21
- 05-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 06-Nov-23
- 17-Nov-23
- 17-Nov-23
- 4
- 07-Feb-23
- 23-Feb-23
- 23-Feb-23
- 8
- 03-Feb-22
- 22-Feb-22
- 21-Feb-22
- 8
- 04-Feb-21
- 19-Feb-21
- 17-Feb-21
- 8
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)